
Novartis Buys Excellergy for $2B, Anthropic Vs. Pentagon, The Mansion Section | Diet TBPN
TBPN
00:00
A proven CEO repeats the formula
John Coogan breaks down Accelergy’s allergy-drug science, funding path, phase one progress, and the repeat-success record of CEO Todd Zavodnik.
Play episode from 03:21
Transcript


